Increase in Neurological Diseases Propelling the Demand for Optogenetics Actuators Across the Globe

Published: Sep 2019

The global optogenetics actuators market is growing at a significant CAGR during the forecast period. Optogenetics technology uses light to control the activity of neurons that are genetically defined. The cells are first developed genetically to indicate a light-sensitive opsin, which is primarily light-gated ion channels or pumps that absorb light at a particular wavelength. There are various tools and technologies mainly developed for optogenetics research, these tools technologies work on the principle of light and use it to detect, measure, and control molecular signals and cells in order to understand their functions. There are two types of optogenetics tools such as actuators and sensors. Actuators are genetically encoded tools for light-activated control of proteins whereas sensors genetically-encoded reporters of molecular signals.

Browse the full report description of Global Optogenetics Actuators and Sensors Market Size, Share & Trends Analysis Report, by Product Type (Actuators, Sensors), by Disease Type (Retinal Disorders, Alzheimer’s Disease, Epilepsy, Parkinson’s Disease, Autism, and Others) and Forecast, 2019-2025 at https://www.omrglobal.com/industry-reports/optogenetics-actuators-sensors-market 

Factors Driving Global Optogenetics Actuators Market

  • Government initiatives with increased R&D support
  • Assist in Better understanding of the functioning of brain cells
  • Extensive research in the field of neuroscience and ophthalmology

The global optogenetics actuators market is growing owing to the increasing number of patients with the neurological issue and retinal diseases. The burden of neurological diseases such as Parkinson's disease, Alzheimer's disease, stroke, and epilepsy and so on is increasing from the past two decades. These neurological disorders are the leading cause of death across the globe. Additionally, most widespread disorders are tension-type headaches, migraine, medication overuse headaches, and Alzheimer's disease and other dementias. The primary reason for these types of issues is longer life expectancy. Today, the people who live longer are more prone to dementia. Moreover, the growing population is another factor, more the people more the diseases registered. These disorders are growing in low income and high-income countries both. Due to which the demand for optogenetics actuators is increasing to control these issues.

Retinal disorders such as floaters, diabetic eyes, macular degeneration, retinal detachment and so on are increasing across the globe which is simultaneously assisting in the rise in demand for optogenetics actuators. Most of these diseases are caused due to unhealthy lifestyle of people and the increase in the use of smartphones and computers in our daily life. Moreover, governments across the globe are taking initiatives and investing in R&D of healthcare treatment and research institutes to improve the livelihood of the citizens. Additionally, various international organizations are taking initiative such as WHO and NIH hence, contributing to the growth of optogenetics accumulators in the market. Moreover, advancement in the field of neuroscience and ophthalmology is another factor which is promoting growth.

Global Optogenetics Actuators Market- Segmentation

By Product Type

  • Actuators
  • Sensors

By Disease Type

  • Alzheimer’s Disease
  • Retinal Disorders
  • Parkinson’s Disease
  • Epilepsy
  • Autism
  • Others

Global Optogenetics Actuators Market -Region

North America

  • US
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe

Asia-Pacific

  • China
  • India
  • Japan
  • Rest of Asia-Pacific

Rest of the World

  • Latin America
  • Middle East and Africa

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/optogenetics-actuators-sensors-market